Most People Initiating Opioid Rx Have Very Low Use Trajectory
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Aug. 14, 2023 -- Most adults initiating treatment with prescription opioids have relatively low and time-limited exposure to opioids during a five-year period, according to a study published online Aug. 10 in JAMA Network Open.
Natasa Gisev, Ph.D., from the National Drug and Alcohol Research Centre in Sydney, and colleagues examined five-year trajectories of prescription opioid use. The analysis included national pharmaceutical claims data linked to 10 national and state datasets for 3.47 million adults initiating an opioid prescription.
The researchers found that the five trajectories included: very low use (75.4 percent), low use (16.6 percent), moderate decreasing to low use (2.6 percent), low increasing to moderate use (2.6 percent), and sustained use (2.8 percent). Individuals in the sustained use trajectory group were older than those in the very low use trajectory group (age 65 years and older: 58.4 versus 22.0 percent); had more comorbidities, including cancer (22.2 versus 4.1 percent); had increased health services contact, including hospital admissions (51.6 versus 36.9 percent); had higher use of psychotropic (42.4 versus 16.4 percent) and other analgesic drugs (47.3 versus 22.9 percent) prior to opioid initiation; and were initiated on stronger opioids (50.2 versus 20.0 percent).
"Information on the individual characteristics of people with different trajectories of opioid use may be used to prevent future harms from long-term opioid use through targeted monitoring and interventions," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Survival Gains Seen With Assignment to Experimental Group in Cancer Trials
TUESDAY, April 30, 2024 -- For patients with solid tumors, assignment to an experimental group in trials of investigational drugs yields significant survival gains, according to a...
Variation ID'd in Risk for Second Primary Cancer After Breast Cancer
TUESDAY, April 30, 2024 -- The risk for second primary cancer (SPC) after breast cancer (BC) varies with gender, age, and socioeconomic status, according to a study published...
People With Opioid Use Disorder Less Likely to Receive Palliative Care
MONDAY, April 29, 2024 -- People with opioid use disorder (OUD) are less likely to receive palliative care during the last 90 days before death, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.